| Download as PDF | |
UCBBrussels, Belgium
Report FactsCompany name: UCB S.A.Fiscal year end: December 31, 2009 Report title: Delivering for patients through innovation Chief Executive Officer: Roch Doliveux Number of books: Two + CSR report. Report length: 68 + 92 + 38 pages. Auditors: PricewaterhouseCoopers AB Design: Comfi E-mail: antje.witte@ucb.com |
Report Rating(Rating scale below) Profile-Products (Excerpts, as from the report)UCB aspires to be the patient-centric global biopharmaceutical leader transforming the lives of people living with severe diseases. Major products address central nervous system diseases (epilepsy, Parkinson’s) and immunology (rheumatoid arthritis, bone loss disorders...).(Excerpts, as from the report. Italics are own company’s words) Key FiguresRevenue: € 3,116 millionOperating income: € 837 million Net income: € 513 million Earnings per share: € 2.85 Dividend per share: € 0.96 R&D expenses: 21.6% Net financial debt: € 1,752 million Equity: € 4,417 million Number of employees: 9,324 (Source: 2009 figures sourced from the annual report) Competitors - Peers
|
Triple A> A report that skillfully draws a patient-centric thread, and gives a vivid account of research and results.> Year Milestones, Results, Pipeline, Operational Strategies (see selected page), Priorities wrapped up in a few pages and lines. > Pictures tell stories –and make company’s focuses clear. Other visual ingredients (circles, dotted lines, sidebars) give the narrative a strong read appeal, as such and in comparison with wordy reports in the sector. > Each area is introduced with a matter-of-fact introduction About the disease and patients’ unmet needs. |
|
Double A> Smart use of all covers -which all convey a message- also as a packaging for the twin-book format.> Short case stories spread all across, also for Research and Development sections. |
|
Simple A> (Just a few) Key Data charted in the inside front cover. More Key Figures are set forth on the last page (why there? Why not?) and span over 3 years but without ratios.> Investor information and share indicators in the inside back cover. > Fair disclosure of governance policies, but remuneration details lag behind best practice. > Simply structured and not fully optimized yet visitor-friendly corporate and IR website. > The first CSR report revolves around Patients, People, Planet and Ethics and is designed with consistency to address those matters in a lively tone. |
|
B Sides> A mission, but where can the real company profile?> The Operating and Financial Review comes late in the second book, is not as legible as the first book (though not as worse as the usual 10-K or 20-F), is often short on comments and even purely descriptive e.g. on financial condition and liquidity matters. And there is a big lack of ratios, left to readers’ calculators. > First ever CSR report only published in May 2010. A laudable effort, lacking in measures, figures and targets. > Paper savings within reach? Lots of blank spaces, two pages for notes. More fundamentally, some might find some sections not elaborate enough compared with many big pharma long-winded books. |
|
|
How does the company report in key areas? What are the main report pluses and minuses?
The Report Scan gives an overview of strengths and weaknesses, and scores each item.
|
|
Selected Page(p 18 of UCB Annual report 2009)
|
|
Reportwatch
"Reviewing a company yearly is the minimum diligence required for investors"The Annual Reports Library
REPORT OF THE MONTH
REPORT OF THE MONTH
Electrolux (September 2010)
BEST ANNUAL REPORTS
Annual Report on Annual Reports 2010
Financial sector annual reports
Annual Report on Annual Reports
For the second consecutive year annual reports from the financial sector have not been selected for our competition. This does not imply that there are not good and better reports in the sector. However, for consistency, comparability and credibility reasons it has been decided not to include any.
How is your report doing?
How does your annual report score on all evaluation criteria used for the Annual Report on Annual Reports?
Order a REPORT SCAN. An edited output of desk research done by e.com report analysts, it provides your company (or advisers) with the complete score breakdown for 50 report items plus a summary of pluses and minuses for each of them.
For more information, click here.
E-mail your order to: e.com@reportwatch.net
Report, google and watch
Has a/your report appeared on ReportWatch?
Has a/your (company) report/name been mentioned, watched, rated, ranked, benchmarked, cited on ReportWatch?
Or has ReportWatch been cited with reference to a/your company/report/name?
Type the (company) name followed by ReportWatch (in one word) and see if you get results.
Not just another report on capitalism
The seven deadly sins of capitalism,
by e.com founder Mike Guillaume
One thing is certain: for all its virtues, and there are still some, the market no longer has all the answers to all the problems.
Read chapters and much more about the economics, capitalism, alternatives on http://www.mikeconomics.net
